secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001093557-26-000072
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q1 revenue $1.19B (+15% YoY), EPS $0.51; raises margin guidance
----------------------------------------------------------------------

- Q1 revenue $1.192B (+15% YoY); GAAP diluted EPS $0.51, non-GAAP $0.56.
- US revenue +11%, international +26% reported (+17% organic) YoY.
- GAAP operating margin 21.4% (+850 bps); non-GAAP 22.2% (+840 bps).
- FY2026 guidance: revenue $5.16-5.25B; non-GAAP op margin raised to 23-23.5%.
- Cash and marketable securities $2.42B; revolver undrawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/0001093557-26-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/dxcm-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001093557-26-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer